Epstein Secrets

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.1 <5.0 (talc) <130 mg/dL (talc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular risk according

TREAL CIRCLE. IIICICER GA 30014.6802 Laboratory Director. ANDREW N YOUNG.AID.PHD.CLIA: 1100255931 MI QUEST DIAGNOSTICS.NIIAMI HMO COMMERCE PARKWAY. MIRAMAR. FL 330254938 Laboratory DUCCIOI: JULIE I. FRIEDMAN.MD.CLIA: If/002773M TP QUEST DIAGNOSTICSTAMPA.1223 E FOWLER AVE TAMPA. It 33617.2026 Laboratory

dL 11.0-15.0 % 140-400 Thousand/uL 7.5-12.5 fL 1500-7800 cells/uL 850-3900 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL Lab MI HS CRP PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. HMO COMMERCE PARKWAY. MIRAMAR. FL 33015.3938 Laboratocc Outdo': JULIE I. FRIEDMAN.MD.CLIA. IOD0277334

00 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL Lab MI HS CRP PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. HMO COMMERCE PARKWAY. MIRAMAR. FL 33015.3938 Laboratocc Outdo': JULIE I. FRIEDMAN.MD.CLIA. IOD0277334 CLIENTSERVICES:866.697.8378 SPECIMEN: MR486858P Quest. Quest Diagnostics,

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

MEAL CIRCLE.11JCICER. GA 30084-6S02 Laboratocy Duccior ANDREW N YOUNG.MD.PIID.CLIA: I I D0255931 MI QUIST DIAGNOSTICS-MIAML 1 two COMMERCE PARKWAY. MIRAMAR. FL 33015.3938 Laboratory DIrector GLEN L NORM MD PHD. CL1A: 10110277312 TP QUEST DIAGNOSTICS-TAMPA. 4225 E FOWLER AVE TAMPA. FL 33617.2026 Laborat

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 0.9 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

0 ng/mL Physician Comments: PENDING TESTS: LIPOPROTEIN (a) MERCURY. BLOOD PERFORMING SITE: MI QUEST DIAGNOSTICS.MIM.H. 10330 COMMERCE PARKWAY. MIRAMAR. FL 33025.3938 Laboratory Director: GLEN L HORTIN MD PHD. CLIA: I0002773M TP QUEST DIAGNOSTICSTAMPA. 1225 E FOWLER AVE TAMPA. It 33617:2026 Laborat

heart disease. CHOL/HDLC RATIO 8.4 H NON HDL CHOLESTEROL 186 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.8 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

provided for informational/educational purposes only.) Physician Comments: PERFORMING SITE: MI QUEST DIAGNOSTICS.MIANII. I0200COMMERCE PARKWAY. MIRAMAR. FL 33015.3938 Labormory Director GLEN L. HORTIN MD PHD. GLIA. 10D0277334 TP QUEST DIAGNOSTICS.TAMPA. 4225 F. FOWLER AVE TAMPA. 11. 33617.2026 Labo

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 mg/dL (talc) <5.0 (talc) <130 mg/dL (talc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular r

rovided for informational/ educational purposes only.) Physician Comments: PERFORMING SITE: MI QUEST DIAGNOSTICS.NIIAMI. 10330 COMMERCE PARKWAY. MIRAMAR. FL 33015-3915 Laboratory DUCCIOI: GLEN L. IIORTIN MD PHD. CLIA 1 000277334 TP QUEST D1AGNOSTICSTAMPA. 1225 E FOWLER AVE TAMPA. FL 33617.2026 Labor

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

ents: PENDING TESTS: CALCIUM, CN1ZED MERCURY. BLOOD IMMUNOFMATION, SERUM PERFORMING SITE: M: QUEST DIAONOSTICS311.kML 102011 COMMERCE PARKWAY. MIRAMAR. FL 33025403S Laboratory Director GLEN L. MARTIN MD rilD. CL1A ItIOA271.114 IP QUEST DIAONOSTICSTAMPA,0.75 E. FOWLER AVE, TAMPA, FL33617-2026 Labor

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

NTREAL CIRCLE.11JCICER. GA 30084-6S02 laboratory Dutch:. ANDREW N YOUNG.MD.PIID.CLIA: 1100255931 MI QUEST DIAGNOSTICS.MIAMI 10200 COMMERCE PARKWAY. MIRAMAR. Fl. 33015-3938 Laboratory Director GLEN L 11OR11N MD PHD. CLIA: 10/1027731/ TP QUEST DIAGNOSTICS.TAMPA. 1223 E FOWLER AVE TAMPA. It 33617.2026 Lab

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

ents: PENDING TESTS: CALCIUM, CN1ZED MERCURY. BLOOD IMMUNOFMATION, SERUM PERFORMING SITE: M: QUEST DIAONOSTICS311.kML 102011 COMMERCE PARKWAY. MIRAMAR. FL 33025403S Laboratory Director GLEN L. MARTIN MD rilD. CL1A ItIOA271.114 IP QUEST DIAONOSTICSTAMPA,0.75 E. FOWLER AVE, TAMPA, FL33617-2026 Labor